Itron (NASDAQ: ITRI) director amends Form 4 stock grant filing

Rhea-AI Filing Summary

Itron, Inc. director stock activity: A member of Itron's board of directors reported receiving a grant of 220 shares of common stock on 01/02/2026 as part of the quarterly compensation that independent directors receive for board service. The shares were reported at a price of $0, reflecting that they were granted, not purchased in the market. Following this grant, the director beneficially owned 15,773 shares directly.

The filing notes that the director, Mr. Leyden, deferred receipt of 82 of these shares under Itron's Executive Deferred Compensation Plan. The amendment also corrects an earlier arithmetic error by adding 9 shares that were inadvertently omitted in a prior report.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider LEYDEN TIMOTHY M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	220	$0.00	--

Holdings After Transaction: Common Stock — 15,773 shares (Direct)

Footnotes (1)

1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 82 shares pursuant to Itron's Executive Deferred Compensation Plan. This amendment is being filed to include 9 shares inadvertently omitted due to an arithmetic error.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEYDEN TIMOTHY M

(Last) (First) (Middle)

2111 N. MOLTER ROAD

(Street)

LIBERTY LAKE WA 99019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
01/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		220(1)	A	$0	15,773(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 82 shares pursuant to Itron's Executive Deferred Compensation Plan.

2. This amendment is being filed to include 9 shares inadvertently omitted due to an arithmetic error.

	/s/ Christopher E. Ware, attorney-in-fact	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Itron (ITRI) report in this Form 4/A?

The filing reports that an Itron, Inc. director received a grant of 220 shares of common stock on 01/02/2026 as part of regular board compensation.

How many Itron (ITRI) shares does the director own after this transaction?

After the reported grant, the director beneficially owned 15,773 shares of Itron common stock in direct ownership.

Why is this Itron (ITRI) Form 4 filed as an amendment (Form 4/A)?

The report is amended to include 9 shares that were inadvertently omitted due to an arithmetic error in a previous filing.

What portion of the Itron (ITRI) stock grant was deferred by the director?

The filing states that Mr. Leyden deferred receipt of 82 shares under Itron's Executive Deferred Compensation Plan.

Was the Itron (ITRI) director’s stock grant a market purchase?

No. The 220 shares were granted at a reported price of $0, reflecting rather than an open-market purchase.

What role does the reporting person have at Itron (ITRI)?

The reporting person is identified as a Director of Itron, Inc., and the grant is described as part of compensation for board service.